Cargando…

Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments

OBJECTIVE: To perform a meta-analysis of randomized, blinded, multiple sclerosis (MS) clinical trials, to test the hypothesis that efficacy of immunomodulatory disease-modifying therapies (DMTs) on MS disability progression is strongly dependent on age. METHODS: We performed a literature search with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weideman, Ann Marie, Tapia-Maltos, Marco Aurelio, Johnson, Kory, Greenwood, Mark, Bielekova, Bibiana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686062/ https://www.ncbi.nlm.nih.gov/pubmed/29176956 http://dx.doi.org/10.3389/fneur.2017.00577

Ejemplares similares

New Multiple Sclerosis Disease Severity Scale Predicts Future Accumulation of Disability
por: Weideman, Ann Marie, et al.
Publicado: (2017)

Smartphone Level Test Measures Disability in Several Neurological Domains for Patients With Multiple Sclerosis
por: Boukhvalova, Alexandra K., et al.
Publicado: (2019)

Pioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes
por: Natrajan, Muktha S., et al.
Publicado: (2015)

Cerebrospinal Fluid Biomarkers of Myeloid and Glial Cell Activation Are Correlated With Multiple Sclerosis Lesional Inflammatory Activity
por: Masvekar, Ruturaj, et al.
Publicado: (2021)

Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials
por: Zhang, Yinan, et al.
Publicado: (2020)

Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment
por: Kosa, Peter, et al.
Publicado: (2016)

Biomarkers in Multiple Sclerosis
por: Martin, Roland, et al.
Publicado: (2006)

Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms
por: Kosa, Peter, et al.
Publicado: (2022)

Current Status and Future Opportunities in Modeling Clinical Characteristics of Multiple Sclerosis
por: Liu, Joshua, et al.
Publicado: (2022)

Intrathecal, Not Systemic Inflammation Is Correlated With Multiple Sclerosis Severity, Especially in Progressive Multiple Sclerosis
por: Milstein, Joshua L., et al.
Publicado: (2019)

Confounder-adjusted MRI-based predictors of multiple sclerosis disability
por: Kim, Yujin, et al.
Publicado: (2022)

Extensive Healthy Donor Age/Gender Adjustments and Propensity Score Matching Reveal Physiology of Multiple Sclerosis Through Immunophenotyping
por: Hannikainen, Paavali A., et al.
Publicado: (2020)

How Implementation of Systems Biology into Clinical Trials Accelerates Understanding of Diseases
por: Bielekova, Bibiana, et al.
Publicado: (2014)

Quantifications of CSF Apoptotic Bodies Do Not Provide Clinical Value in Multiple Sclerosis
por: Masvekar, Ruturaj, et al.
Publicado: (2019)

Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis
por: Lin, Yen Chih, et al.
Publicado: (2015)

Finger and foot tapping as alternative outcomes of upper and lower extremity function in multiple sclerosis
por: Tanigawa, Makoto, et al.
Publicado: (2017)

Smartphone-based symbol-digit modalities test reliably captures brain damage in multiple sclerosis
por: Pham, Linh, et al.
Publicado: (2021)

Cognitive Profiles of Aging in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2019)

Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
por: Komori, Mika, et al.
Publicado: (2016)

Machine learning-optimized Combinatorial MRI scale (COMRISv2) correlates highly with cognitive and physical disability scales in Multiple Sclerosis patients
por: Kelly, Erin, et al.
Publicado: (2022)

A Complex Role of Herpes Viruses in the Disease Process of Multiple Sclerosis
por: Wuest, Simone C., et al.
Publicado: (2014)

The Efficacy of Psychological Interventions for Managing Fatigue in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Phyo, Aung Zaw Zaw, et al.
Publicado: (2018)

Assessment of Smartphone-Based Spiral Tracing in Multiple Sclerosis Reveals Intra-Individual Reproducibility as a Major Determinant of the Clinical Utility of the Digital Test
por: Messan, Komi S., et al.
Publicado: (2022)

Subjective Cognitive Fatigue in Multiple Sclerosis Depends on Task Length
por: Sandry, Joshua, et al.
Publicado: (2014)

Aging, Cellular Senescence, and Progressive Multiple Sclerosis
por: Papadopoulos, Dimitrios, et al.
Publicado: (2020)

1820. Efficacy of Pulse-Taper Corticosteroid Adjunctive Therapy for Refractory Non-HIV Cryptococcal Meningoencephalitis
por: Anjum, Seher, et al.
Publicado: (2019)

Management of multiple sclerosis fatigue in the digital age: from assessment to treatment
por: Pinarello, Chiara, et al.
Publicado: (2023)

Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients
por: Bai, Zhile, et al.
Publicado: (2019)

Oxidative Stress Marker Aberrations in Multiple Sclerosis: A Meta-Analysis Study
por: Zhang, Shu-Yao, et al.
Publicado: (2020)

Multidisciplinary Rehabilitation is Efficacious and Induces Neural Plasticity in Multiple Sclerosis even when Complicated by Progressive Multifocal Leukoencephalopathy
por: Groppo, Elisabetta, et al.
Publicado: (2017)

NeurEx: digitalized neurological examination offers a novel high‐resolution disability scale
por: Kosa, Peter, et al.
Publicado: (2018)

Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions
por: Musella, Alessandra, et al.
Publicado: (2018)

Adverse Childhood Experiences Are Linked to Age of Onset and Reading Recognition in Multiple Sclerosis
por: Shaw, Michael T., et al.
Publicado: (2017)

KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis
por: Wunsch, Marie, et al.
Publicado: (2014)

The prevalence and risk factors of anxiety in multiple sclerosis: A systematic review and meta-analysis
por: Zhang, Xiaoyun, et al.
Publicado: (2023)

Epigenetic clock indicates accelerated aging in glial cells of progressive multiple sclerosis patients
por: Kular, Lara, et al.
Publicado: (2022)

Cognitive Dysfunction in Multiple Sclerosis
por: Guimarães, Joana, et al.
Publicado: (2012)

Editorial: Fatigue in Multiple Sclerosis
por: Dettmers, Christian, et al.
Publicado: (2015)

Remyelination Therapy in Multiple Sclerosis
por: Harlow, Danielle E., et al.
Publicado: (2015)

Cerebellar Dysfunction in Multiple Sclerosis
por: Wilkins, Alastair
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_esg1ure7srci0fjhfql0bmhtd6